- Home
- ARDX vs CIM Comparison
ARDX vs CIM Comparison
Compare ARDX & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- CIM
- Stock Information
- Founded
- ARDX 2007
- CIM 2007
- Country
- ARDX United States
- CIM United States
- Employees
- ARDX N/A
- CIM N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- CIM Real Estate Investment Trusts
- Sector
- ARDX Health Care
- CIM Real Estate
- Exchange
- ARDX Nasdaq
- CIM Nasdaq
- Market Cap
- ARDX 1.3B
- CIM 965.2M
- IPO Year
- ARDX 2014
- CIM 2007
- Fundamental
- Price
- ARDX $3.64
- CIM $12.79
- Analyst Decision
- ARDX Strong Buy
- CIM Hold
- Analyst Count
- ARDX 8
- CIM 2
- Target Price
- ARDX $10.19
- CIM $16.00
- AVG Volume (30 Days)
- ARDX 6.4M
- CIM 533.6K
- Earning Date
- ARDX 05-01-2025
- CIM 05-08-2025
- Dividend Yield
- ARDX N/A
- CIM 11.56%
- EPS Growth
- ARDX N/A
- CIM N/A
- EPS
- ARDX N/A
- CIM 1.52
- Revenue
- ARDX $361,706,000.00
- CIM $326,755,000.00
- Revenue This Year
- ARDX $15.74
- CIM $11.59
- Revenue Next Year
- ARDX $34.56
- CIM $2.13
- P/E Ratio
- ARDX N/A
- CIM $8.43
- Revenue Growth
- ARDX 127.33
- CIM 11.90
- 52 Week Low
- ARDX $3.62
- CIM $9.85
- 52 Week High
- ARDX $9.20
- CIM $16.89
- Technical
- Relative Strength Index (RSI)
- ARDX 32.40
- CIM 59.93
- Support Level
- ARDX $3.62
- CIM $11.96
- Resistance Level
- ARDX $5.65
- CIM $12.52
- Average True Range (ATR)
- ARDX 0.31
- CIM 0.33
- MACD
- ARDX -0.15
- CIM 0.16
- Stochastic Oscillator
- ARDX 6.53
- CIM 78.95
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.